Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Dave Pulford from Yeovil, Somerset, underwent a procedure in which he swallowed a balloon to help him lose weight ahead of ...

Participants who had protein bars enriched with collagen not only saw greater weight loss results but also improved ...

A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...

GLP-1s used in combination with the Virtual Care Suite led to an average gain in lean body mass of 6.1%, the company said. Data was also presented showing that Allurion Balloon used in combination ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

Karan Johar says he has been following the one-meal-a-day diet, or OMAD, for the last six to seven months, which led to his weight loss. Eating one meal a day is a type of intermittent fasting that ...

Novo Nordisk A/S NVO is seeking FDA approval for the pill version of its obesity drug ... oral semaglutide experienced “16.6% average weight loss,” Lange says, with one-third of participants ...

Weight loss hack: Simple snack swap shown to turbocharge belly fat breakdown and cholesterol removal - Swapping high-carbohydrate snacks for tree nuts could help young adults reduce their risk of ...

As such, pharma companies are racing to bring a weight loss pill to market. Eli Lilly recently said it expects its candidate to secure FDA approval in 2026. Roche and AstraZeneca are also tying to ...